Pharmacological effects of cannabidiol by transient receptor potential channels
L Etemad, G Karimi, MS Alavi, A Roohbakhsh - Life Sciences, 2022 - Elsevier
Cannabidiol (CBD), as a major phytocannabinoid of Cannabis sativa, has emerged as a
promising natural compound in the treatment of diseases. Its diverse pharmacological …
promising natural compound in the treatment of diseases. Its diverse pharmacological …
[HTML][HTML] Cannabinoids as medicinals
JH Khalsa, G Bunt, K Blum, SB Maggirwar… - Current addiction …, 2022 - Springer
Purpose of review There have been many debates, discussions, and published writings
about the therapeutic value of cannabis plant and the hundreds of cannabinoids it contains …
about the therapeutic value of cannabis plant and the hundreds of cannabinoids it contains …
Clinical management of cannabis withdrawal
Abstract Background and Aims Cannabis withdrawal is a well‐characterized phenomenon
that occurs in approximately half of regular and dependent cannabis users after abrupt …
that occurs in approximately half of regular and dependent cannabis users after abrupt …
[HTML][HTML] Cannabis for Medical Use: Versatile Plant Rather Than a Single Drug
S Procaccia, GM Lewitus, C Lipson Feder… - Frontiers in …, 2022 - frontiersin.org
Medical Cannabis and its major cannabinoids (−)-trans-Δ9-tetrahydrocannabinol (THC) and
cannabidiol (CBD) are gaining momentum for various medical purposes as their therapeutic …
cannabidiol (CBD) are gaining momentum for various medical purposes as their therapeutic …
Synthetic Strategies for Rare Cannabinoids Derived from Cannabis sativa
Efficient syntheses of eight key cannabinoids were established and optimized. Predominant
cannabinoids such as cannabigerol (CBG-C5) and cannabidiol (CBD-C5) were prepared …
cannabinoids such as cannabigerol (CBG-C5) and cannabidiol (CBD-C5) were prepared …
Statement on safety of cannabidiol as a novel food: data gaps and uncertainties
EFSA Panel on Nutrition, Novel Foods and Food … - EFSA …, 2022 - Wiley Online Library
Abstract The European Commission has determined that cannabidiol (CBD) can be
considered as a novel food (NF), and currently, 19 applications are under assessment at …
considered as a novel food (NF), and currently, 19 applications are under assessment at …
[HTML][HTML] Cannabis sativa and skin health: Dissecting the role of phytocannabinoids
G Martinelli, A Magnavacca, M Fumagalli… - Planta …, 2022 - thieme-connect.com
The use of Cannabis sativa is currently recognized to ease certain types of chronic pain,
reduce chemotherapy-induced nausea, and improve anxiety. Nevertheless, few studies …
reduce chemotherapy-induced nausea, and improve anxiety. Nevertheless, few studies …
[HTML][HTML] Cannabidiol interacts antagonistically with cisplatin and additively with mitoxantrone in various melanoma cell lines—An isobolographic analysis
P Marzęda, P Wróblewska-Łuczka, M Drozd… - International Journal of …, 2022 - mdpi.com
The medical application of cannabidiol (CBD) has been gathering increasing attention in
recent years. This non-psychotropic cannabis-derived compound possesses antiepileptic …
recent years. This non-psychotropic cannabis-derived compound possesses antiepileptic …
[HTML][HTML] Minor phytocannabinoids: A misleading name but a promising opportunity for biomedical research
Despite the very large number of phytocannabinoids isolated from Cannabis (Cannabis
sativa L.), bioactivity studies have long remained focused on the so called “Big Four”[Δ9 …
sativa L.), bioactivity studies have long remained focused on the so called “Big Four”[Δ9 …
[HTML][HTML] Antimicrobial and cytotoxic effects of cannabinoids: an updated review with future perspectives and current challenges
The development of new antibiotics is urgently needed to combat the threat of bacterial
resistance. New classes of compounds that have novel properties are urgently needed for …
resistance. New classes of compounds that have novel properties are urgently needed for …